Short Interest in Viemed Healthcare, Inc. (NASDAQ:VMD) Increases By 18.4%

Viemed Healthcare, Inc. (NASDAQ:VMD) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 361,200 shares, an increase of 18.4% from the October 15th total of 305,100 shares. Based on an average trading volume of 155,500 shares, the days-to-cover ratio is currently 2.3 days. Currently, 1.1% of the shares of the stock are sold short.

Viemed Healthcare Price Performance

Shares of VMD stock traded down $0.14 during trading hours on Friday, hitting $8.92. The stock had a trading volume of 116,909 shares, compared to its average volume of 153,938. The stock’s 50-day moving average price is $8.31 and its two-hundred day moving average price is $7.53. Viemed Healthcare has a one year low of $6.21 and a one year high of $10.44. The stock has a market capitalization of $347.32 million, a price-to-earnings ratio of 33.48 and a beta of 1.43. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.08 by $0.02. The company had revenue of $58.00 million during the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Insider Activity at Viemed Healthcare

In related news, Director Nitin Kaushal sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $9.56, for a total transaction of $286,800.00. Following the transaction, the director now directly owns 126,843 shares in the company, valued at $1,212,619.08. This trade represents a 19.13 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the sale, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 20.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Viemed Healthcare

Several hedge funds have recently modified their holdings of the business. Wasatch Advisors LP lifted its position in shares of Viemed Healthcare by 19.6% during the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock valued at $13,552,000 after buying an additional 303,277 shares during the last quarter. Raffles Associates LP raised its stake in shares of Viemed Healthcare by 11.0% during the 3rd quarter. Raffles Associates LP now owns 402,691 shares of the company’s stock worth $2,952,000 after acquiring an additional 40,000 shares in the last quarter. PDT Partners LLC acquired a new stake in Viemed Healthcare in the third quarter valued at approximately $78,000. Walleye Capital LLC purchased a new position in Viemed Healthcare in the third quarter worth $87,000. Finally, Martingale Asset Management L P increased its position in shares of Viemed Healthcare by 28.5% during the third quarter. Martingale Asset Management L P now owns 31,385 shares of the company’s stock worth $230,000 after purchasing an additional 6,965 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.